
世界卫生组织周二宣布,针对正在刚果民主共和国肆虐的致命本迪布焦型埃博拉病毒的两种疫苗将于下周在疫情中心地区进入试验阶段。
Two vaccines against the deadly Bundibugyo Ebola strain gripping the Democratic Republic of Congo are set to enter trials in the outbreak's epicentre next week, the World Health Organization announced on Tuesday.
9月19日,在布尼亚的一个埃博拉疫苗接种中心,一名医护人员正在接种一剂Ervebo疫苗。© 美联社照片/迪厄多内·迪罗尔世界卫生组织总干事谭德塞周二在日内瓦联合国卫生机构总部举行的新闻发布会上表示:“我们预计,专门针对本迪布焦病毒开发的两种候选疫苗最早将于下周开始测试。”
A healthcare worker administers a dose of the Ervebo vaccine at an Ebola vaccination centre in Bunia, 19 September. © AP Photo/Dieudonne Dirole "We expect two candidate vaccines developed specifically for Bundibugyo virus to begin testing as early as next week," World Health Organization (WHO) chief Tedros Adhanom Ghebreyesus told a press conference at the United Nations health agency's headquarters in Geneva on Tuesday.
在刚果民主共和国开展的所谓“图迈尼试验”将测试疫苗的安全性、有效性以及激发免疫反应的能力。
The so-called Tumaini trial in the Democratic Republic of Congo ( DRC ) will test the safety, efficacy and ability to trigger an immune response.
该试验采用环状疫苗接种法,为被认为感染风险较高的接触者接种疫苗。
The trial uses the ring vaccination method of immunising contacts deemed to be at high risk of infection.
Ervebo是一种已获批用于对抗更常见的扎伊尔型埃博拉病毒的疫苗,该疫苗于10月23日启动了图迈尼试验,并直接进入全面的三期阶段,以确定它是否也能对本国迪布焦型病毒提供保护。
Ervebo, a vaccine already approved for use against the more common Zaire strain of Ebola, kicked off the Tumaini trial on 23 October, at the full-scale Phase 3 level, to determine if it also offers any protection against Bundibugyo.
目前,对于较为少见的本迪布焦型埃博拉病毒,尚无疫苗或治疗方法。正是这种病毒引发了今年5月宣布的疫情,并触发了国际公共卫生紧急事件。
There are currently no vaccines or treatments for the less common Bundibugyo species of Ebola, which is responsible for the outbreak declared in May that triggered an international public health emergency.
卫生机构证实,随着疫情达到六个月节点,刚果民主共和国东部的埃博拉疫情仍处于失控状态,病例数和死亡人数仍以创纪录的速度上升。
Health agencies have confirmed that the Ebola outbreak in eastern DRC remains out of control as the epidemic reached the six-month mark, with case numbers and deaths still rising at a record pace.
据世界卫生组织称,在这个中非国家有史以来最严重的埃博拉疫情中,11376例病例中已确认5568例死亡。
A total of 5,568 deaths out of 11,376 cases have been confirmed in what is the central African country's worst-ever Ebola outbreak, according to the WHO.
资源短缺、该国局势不稳以及协调不力,阻碍了遏制疫情的努力。这是全球有记录以来第二严重的埃博拉疫情。
Resource shortages, instability in the country and poor coordination have hampered efforts to contain the outbreak, which is the second-largest on record globally.
刚果(金)埃博拉疫情暴发六个月后仍“失控”,非洲疾控中心警告
不同种类的疫苗正在试验的两种针对本迪布焦型埃博拉病毒的候选疫苗均已通过第一阶段临床试验。其中一种是牛津大学研发的ChAdOx1腺病毒载体疫苗。
Different vaccine types The two Bundibugyo-specific candidate vaccines on trial have both already passed through Phase 1 clinical trials. One is a ChAdOx1 adenoviral vector jab developed by the University of Oxford.
另一种是mRNA-1469,由总部位于美国的莫德纳集团研发,采用的是新冠疫情期间广为人知的技术。
The other, mRNA-1469, was developed by the United States-based Moderna group using technology made famous during the Covid-19 pandemic.
世界卫生组织健康科学部门负责人梅格·多尔蒂表示,候选疫苗的第二阶段临床试验定于11月26日或27日在布尼亚开始。布尼亚是刚果(金)东北部伊图里省的首府,也是此次疫情的中心。
Meg Doherty , head of the WHO's science for health department, said Phase 2 clinical trials with the candidate vaccines are scheduled to begin on 26 or 27 November in Bunia, the capital of the DRC's northeastern Ituri province which is at the epicentre of the outbreak.
如果第二阶段试验的安全性和免疫应答数据通过下一阶段评审,候选疫苗便可推进至全面第三阶段试验。
If the safety and immune response data from the Phase 2 trial pass the next stage of review, the candidate jabs can move forward to a full-scale Phase 3 trial.
多尔蒂表示,“图迈尼”试验已招募超过140人,最终预计将有数千名接触者报名参加。试验最终还将扩展到布尼亚现有的单一试验点之外。
Doherty said that more than 140 people were enrolled in the Tumaini trial, with thousands of contacts ultimately expected to sign up. The trial will also eventually expand beyond the current single site in Bunia.
埃博拉疫苗试验为刚果(金)及其他地区带来“希望的理由”埃博拉病毒通过接触体液传播,会引发出血热。过去50年间,该病毒在非洲已导致超过1.5万人死亡。
Ebola vaccine trials 'reason for hope' in DR Congo and beyond Ebola, which spreads through contact with bodily fluids and causes a haemorrhagic fever, has killed more than 15,000 people in Africa over the past 50 years.
谭德塞表示,每周仍报告400至500例新增病例,三分之二的确诊死亡病例仍发生在埃博拉治疗中心之外。
Tedros said 400 to 500 new cases were still being reported every week, with two-thirds of confirmed deaths still taking place outside Ebola treatment centres.
“儿童正在付出惨痛代价。他们占确诊病例的四分之一以上,占死亡病例的三分之一,”他补充说。(法新社)
"Children are paying a terrible price. They account for more than a quarter of confirmed cases and one third of deaths," he added. (with AFP)